World Journal of Urology

, Volume 25, Issue 5, pp 477–489

The NF-κB/IL-6 pathway in metastatic androgen-independent prostate cancer: new therapeutic approaches?

  • Bernard Paule
  • Stéphane Terry
  • Laurence Kheuang
  • Pascale Soyeux
  • Francis Vacherot
  • Alexandre de la Taille
Review

DOI: 10.1007/s00345-007-0175-6

Cite this article as:
Paule, B., Terry, S., Kheuang, L. et al. World J Urol (2007) 25: 477. doi:10.1007/s00345-007-0175-6

Abstract

The nuclear factor of kappa beta (NF-κB) transcription factor regulates the transcription of numerous genes including that of interleukin 6 (IL-6). The IL-6 acts as an autocrine and paracrine growth factor of androgen-independent prostate cancer. An aberrant expression of the IL-6 gene and an increase in IL-6 expression are detected in bone metastatic and hormone-refractory prostate cancer. IL-6 has been suggested to have a crucial role in the resistance to chemotherapy or hormonal therapy involving apoptotic cell death. The NF-κB/IL-6 dependent pathways promote tumour-cell survival and in most situations protect cells against apoptotic stimuli. These data provide a rational framework for targeting NF-κB and IL-6 activity in novel biologically based therapies for aggressive and androgen independent prostate cancers.

Keywords

Prostate cancerNF-κBIL-6New therapiesAndrogen independenceMetastasis

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Bernard Paule
    • 3
  • Stéphane Terry
    • 1
    • 2
  • Laurence Kheuang
    • 1
    • 2
  • Pascale Soyeux
    • 1
    • 2
  • Francis Vacherot
    • 1
    • 2
  • Alexandre de la Taille
    • 1
    • 2
    • 3
    • 4
  1. 1.INSERM, Unité 841eq07, IMRB, Department of Immunology Dermatology Oncologyéquipe Carcinogénèse et Pathologie Moléculaire des Tumeurs UrologiquesCréteilFrance
  2. 2.Faculté de MédecineUniversité Paris 12CréteilFrance
  3. 3.AP-HP, Groupe Hospitalier Henri Mondor, Service d’UrologieCréteilFrance
  4. 4.INSERM U841EQ07, Department of UrologyCHU MondorCréteilFrance